Identified a New Factor That Disrupts the Brain’s “Waste-Cleanup Function”; Antibody Targeting Improves Alzheimer’s Symptoms in Mice: Innovative Tech

Researchers identified DDR2 as an abnormal driver of Alzheimer’s-related waste-clearance failure in the brain.

DDR2 was elevated in key brain cells and appeared to disrupt fluid circulation, the glymphatic system, and amyloid beta removal.

In mice, a DDR2-degrading antibody called HL2 reduced amyloid beta buildup and improved brain function and cognition.

The findings suggest a new therapeutic target for restoring blood flow, waste clearance, and cognitive performance in Alzheimer’s disease.